Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK

PURPOSE: For patients with chronic obstructive pulmonary disease (COPD) who remain symptomatic despite maintenance treatment, clinical management guidelines recommend a stepwise escalation from monotherapy to dual therapy, and from dual therapy to triple therapy. However, in clinical practice, patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kendall, Robyn, Martin, Alan A, Shah, Dhvani, Shukla, Soham, Compton, Chris, Ismaila, Afisi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454752/
https://www.ncbi.nlm.nih.gov/pubmed/37636901
http://dx.doi.org/10.2147/COPD.S400707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454752/
https://www.ncbi.nlm.nih.gov/pubmed/37636901
http://dx.doi.org/10.2147/COPD.S400707

Ejemplares similares